Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard Rees Insider Profile
4 Followers
Richard Rees, Chief Financial Officer at Creo Medical, holds 3.04M shares in Creo Medical (Ticker: GB:CREO). Most recently, Richard Rees Bought 208,333p shares of Creo Medical on Oct 01, 2024 for an estimated value of 50.00K.
Richard Rees Creo Medical (CREO)Chief Financial Officer
Creo Medical (CREO)
Chief Financial Officer
Ranked #78,701 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-28.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Richard Rees holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard Rees
Richard Rees's Trading History
List of latest transactions for each holding click on a transaction to see Richard Rees's performance on stock
You May Also Like
Richard Rees insider profile FAQ
What is the percentage of profitable transactions made by Richard Rees?
The percentage of profitable transactions made by Richard Rees is 33%.
What is the average return per transaction made by Richard Rees?
The average return per transaction made by Richard Rees is -28.20%.
What stocks does Richard Rees hold?
Richard Rees holds: GB:CREO stocks.
What was Richard Rees’s latest transaction?
Richard Rees latest transaction was an Informative Buy of 50.00K.
What was Richard Rees's most profitable transaction?
Richard Rees’s most profitable transaction was an Informative Buy of GB:CREO stock on February 17, 2023. The return on the trade was 1.70%.
What is Richard Rees's role in Creo Medical?
Richard Rees's role in Creo Medical is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.